Rosati G - Search Results

1

Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial.

Aschele C, Cionini L, Lonardi S, Pinto C, Cordio S, Rosati G, Artale S, Tagliagambe A, Ambrosini G, Rosetti P, Bonetti A, Negru ME, Tronconi MC, Luppi G, Silvano G, Corsi DC, Bochicchio AM, Chiaulon G, Gallo M, Boni L. Aschele C, et al. Among authors: rosati g. J Clin Oncol. 2011 Jul 10;29(20):2773-80. doi: 10.1200/JCO.2010.34.4911. Epub 2011 May 23. J Clin Oncol. 2011. PMID: 21606427 Clinical Trial.

2

Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase II randomized study.

Caponigro F, Rosati G, De Rosa P, Avallone A, De Rosa V, De Lucia L, Comella P, Comella G. Caponigro F, et al. Among authors: rosati g. Oncology. 2002;63(3):232-8. doi: 10.1159/000065470. Oncology. 2002. PMID: 12381902 Clinical Trial.

3

A phase II study of irinotecan alternated with a weekly schedule of oxaliplatin, high-dose leucovorin and 48-hour infusion 5-fluorouracil in patients with advanced colorectal cancer.

Rosati G, Tucci A, Rinaldi A, Colarusso D, Pizza C, Reggiardo G, Manzione L. Rosati G, et al. Oncology. 2004;66(5):371-8. doi: 10.1159/000079485. Oncology. 2004. PMID: 15331924 Clinical Trial.

4

Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale.

Colucci G, Gebbia V, Paoletti G, Giuliani F, Caruso M, Gebbia N, Cartenì G, Agostara B, Pezzella G, Manzione L, Borsellino N, Misino A, Romito S, Durini E, Cordio S, Di Seri M, Lopez M, Maiello E, Montemurro S, Cramarossa A, Lorusso V, Di Bisceglie M, Chiarenza M, Valerio MR, Guida T, Leonardi V, Pisconti S, Rosati G, Carrozza F, Nettis G, Valdesi M, Filippelli G, Fortunato S, Mancarella S, Brunetti C; Gruppo Oncologico Dell'Italia Meridionale. Colucci G, et al. Among authors: rosati g. J Clin Oncol. 2005 Aug 1;23(22):4866-75. doi: 10.1200/JCO.2005.07.113. Epub 2005 Jun 6. J Clin Oncol. 2005. PMID: 15939922 Clinical Trial.

5

Phase II trial of oxaliplatin and tegafur/uracil and oral folinic acid for advanced or metastatic colorectal cancer in elderly patients.

Rosati G, Cordio S, Tucci A, Blanco G, Bordonaro R, Reggiardo G, Manzione L. Rosati G, et al. Oncology. 2005;69(2):122-9. doi: 10.1159/000087814. Epub 2005 Aug 23. Oncology. 2005. PMID: 16118508 Clinical Trial.

6

Single-agent irinotecan as second-line weekly chemotherapy in elderly patients with advanced colorectal cancer.

Rosati G, Cordio S. Rosati G, et al. Tumori. 2006 Jul-Aug;92(4):290-4. doi: 10.1177/030089160609200405. Tumori. 2006. PMID: 17036518

7

Discontinuation of bevacizumab and FOLFIRI administered up to a maximum of 12 cycles as first-line therapy for metastatic colorectal cancer: a retrospective Italian study.

Rosati G, Cordio S, Aprile G, Butera A, Avallone A, Di Lucca G, De Pauli F, Parra HS, Reggiardo G, Bordonaro R. Rosati G, et al. Invest New Drugs. 2012 Oct;30(5):1978-83. doi: 10.1007/s10637-011-9721-6. Epub 2011 Jul 19. Invest New Drugs. 2012. PMID: 21769636 Clinical Trial.

8

Bevacizumab and first-line chemotherapy for older patients with advanced colorectal cancer: final results of a Community-based Observational Italian Study.

Lutrino SE, Bergamo F, Schirripa M, Rosati G, Avallone A, Giampieri R, Cordio S, Berretta M, Llimpe FR, Pisa FE, Lonardi S, Loupakis F, Fasola G, Aprile G. Lutrino SE, et al. Among authors: rosati g. Anticancer Res. 2015 Apr;35(4):2391-9. Anticancer Res. 2015. PMID: 25862905 Clinical Trial.

9

A perspective on the current treatment strategies for locally advanced rectal cancer.

Avallone A, Aloj L, Aprile G, Rosati G, Budillon A. Avallone A, et al. Among authors: rosati g. Int J Biochem Cell Biol. 2015 Aug;65:192-6. doi: 10.1016/j.biocel.2015.06.002. Epub 2015 Jun 6. Int J Biochem Cell Biol. 2015. PMID: 26055517 Review.

10

Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world.

Fanotto V, Cordio S, Pasquini G, Fontanella C, Rimassa L, Leone F, Rosati G, Santini D, Giampieri R, Di Donato S, Tomasello G, Silvestris N, Pietrantonio F, Battaglin F, Avallone A, Scartozzi M, Lutrino ES, Melisi D, Antonuzzo L, Pellegrino A, Torri V, Aprile G. Fanotto V, et al. Among authors: rosati g. Gastric Cancer. 2017 Sep;20(5):825-833. doi: 10.1007/s10120-016-0681-6. Epub 2016 Dec 27. Gastric Cancer. 2017. PMID: 28028664

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

456 results

Search Page

Filters